Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 1
2006 1
2009 1
2012 1
2017 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Breast Micropapillary Ductal Carcinoma In Situ"
Page 1
Triple-Positive Breast Carcinoma: Histopathologic Features and Response to Neoadjuvant Chemotherapy.
Zeng J, Edelweiss M, Ross DS, Xu B, Moo TA, Brogi E, D'Alfonso TM. Zeng J, et al. Arch Pathol Lab Med. 2021 Jun 1;145(6):728-735. doi: 10.5858/arpa.2020-0293-OA. Arch Pathol Lab Med. 2021. PMID: 33112958 Free PMC article.
.-: It is unclear whether HER2+ tumors expressing both estrogen receptor (ER) and progesterone receptor (PR), that is, triple-positive breast carcinomas (TPBCs), show unique morphologic and clinical features and response to neoadjuvant chemotherapy (NAC). ...RESULTS …
.-: It is unclear whether HER2+ tumors expressing both estrogen receptor (ER) and progesterone receptor (PR), that is, triple-positive br …
Sentinel node biopsy in ductal carcinoma in situ patients.
Pendas S, Dauway E, Giuliano R, Ku N, Cox CE, Reintgen DS. Pendas S, et al. Ann Surg Oncol. 2000 Jan-Feb;7(1):15-20. doi: 10.1007/s10434-000-0015-z. Ann Surg Oncol. 2000. PMID: 10674443 Clinical Trial.
METHODS: At Moffitt Cancer Center, 87 patients with newly diagnosed pure ductal carcinoma in situ (DCIS) lesions were evaluated by using CK IHC staining of the SLN. ...Of interest, four of the five node-positive patients had comedo carcinoma ass …
METHODS: At Moffitt Cancer Center, 87 patients with newly diagnosed pure ductal carcinoma in situ (DCIS) lesions …
Secondary breast carcinoma after completely remitted chronic myeloid leukemia following targeted tyrosine kinase inhibitor therapy.
Pan L, Duan J, Qiao W, Bi L, Wu D, Fan Z, Yang M. Pan L, et al. Breast Cancer. 2017 Nov;24(6):790-793. doi: 10.1007/s12282-017-0786-8. Epub 2017 Jun 5. Breast Cancer. 2017. PMID: 28585003
Four years later, the patient noticed a firm and painless lump in the left breast, which was diagnosed as ductal carcinoma in situ based on a percutaneous biopsy of the mass. Simple resection and sentinel lymph node biopsy of the left breast …
Four years later, the patient noticed a firm and painless lump in the left breast, which was diagnosed as ductal carcinoma …
Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.
EORTC Breast Cancer Cooperative Group; EORTC Radiotherapy Group; Bijker N, Meijnen P, Peterse JL, Bogaerts J, Van Hoorebeeck I, Julien JP, Gennaro M, Rouanet P, Avril A, Fentiman IS, Bartelink H, Rutgers EJ. EORTC Breast Cancer Cooperative Group, et al. J Clin Oncol. 2006 Jul 20;24(21):3381-7. doi: 10.1200/JCO.2006.06.1366. Epub 2006 Jun 26. J Clin Oncol. 2006. PMID: 16801628 Clinical Trial.
PURPOSE: The European Organisation for Research and Treatment of Cancer conducted a randomized trial investigating the role of radiotherapy (RT) after local excision (LE) of ductal carcinoma-in-situ (DCIS) of the breast. We analyze …
PURPOSE: The European Organisation for Research and Treatment of Cancer conducted a randomized trial investigating the role of …
Intracystic papillary carcinoma of the male breast: a case report and review of the literature.
Hussain A, Sweeney KJ, Salman R, Callagy GM, Sweeney I, McLaughlin R. Hussain A, et al. Ir J Med Sci. 2012 Sep;181(3):329-31. doi: 10.1007/s11845-009-0372-y. Epub 2009 Jul 9. Ir J Med Sci. 2012. PMID: 19588226 Review.
MATERIALS AND METHODS: Herein we describe a case of intracystic papillary carcinoma in situ in a male breast with a review of the literature. ...It is characteristically of the papillary and micropapillary subtype. Intracystic papillary carcinoma …
MATERIALS AND METHODS: Herein we describe a case of intracystic papillary carcinoma in situ in a male breast with a rev …
Aggressive local treatment for screen-detected DCIS results in very low rates of recurrence.
Jha MK, Avlonitis VS, Griffith CD, Lennard TW, Wilson RG, McLean LM, Dawes PD, Shrimankar J. Jha MK, et al. Eur J Surg Oncol. 2001 Aug;27(5):454-8. doi: 10.1053/ejso.2001.1163. Eur J Surg Oncol. 2001. PMID: 11504515
AIMS: To review our institution's practice of treatment of a mammographically detected population of ductal carcinoma in situ (DCIS) patients and to determine the outcome. ...CONCLUSIONS: The findings of this study suggest that in women with DCIS suita …
AIMS: To review our institution's practice of treatment of a mammographically detected population of ductal carcinoma in …